PATLY.AIApplication
15882919 · Engineered Polypeptides Having Enhanced Duration of Action and Reduced Immunogenicity
Filed 2018-01-29 · Abandoned The official file ↗ · Art unit 1654 · Examiner Maury A Audet Hard · CPC C07K 14/5759 · Aegerion Pharmaceuticals, Inc. · COOLEY LLP
Office actions
1
first was Restriction requirement
RCEs
0
no appeal
To first action
28.3 mo
to disposition 41.3 mo
Statutes raised
112
1 actions read